Monaldi Archives for Chest Disease (Jan 2016)

Increased IL-6 and IL-4 in exhaled breath condensate of patients with nasal polyposis

  • G.E. Carpagnano,
  • P. Carratù,
  • M. Gelardi,
  • A. Spanevello,
  • G. Di Gioia,
  • T. Condreva,
  • O. Resta,
  • M.P. Foschino Barbaro

DOI
https://doi.org/10.4081/monaldi.2009.369
Journal volume & issue
Vol. 71, no. 1

Abstract

Read online

Background and Aim. Nasal polyposis (NP) occurs in about 1-4% of the worldwide population. Increased plasma concentrations of different pro-inflammatory cytokines have been observed in NP, and might be related to the pathogenesis of this syndrome.The present study was designed to investigate IL-6 and IL-4 concentrations in nasal and oral exhaled breath condensate of patients with early and advanced NP, and following polypectomy. Methods. Ten individuals with polyposis in early status, twenty-three patients affected by advanced status of NP and ten healthy controls were enrolled into the study. Exhaled breath condensate was collected by all individuals, according to a previous standardised method. An immunoassay kit was used to measure IL-6 and IL-4 levels. Results. Concentrations of oral and nasal exhaled IL- 6 and IL-4 were significantly higher in patients with early nasal polyposis and advanced nasal polyposis, compared to healthy controls. A statistically significant decrease of nasally but not of orally exhaled IL-6 (p<0.001) and IL-4 (p<0.05) was observed after polypectomy. Conclusions. We consider oral and nasal exhaled condensate of IL-6 and IL-4 as valid inflammatory and oxidative stress marker in patients with nasal polyposis.

Keywords